251 related articles for article (PubMed ID: 24565770)
41. Association between consistent omalizumab treatment and asthma control.
Lafeuille MH; Gravel J; Zhang J; Gorsh B; Figliomeni M; Lefebvre P
J Allergy Clin Immunol Pract; 2013 Jan; 1(1):51-7. PubMed ID: 24229822
[TBL] [Abstract][Full Text] [Related]
42. TENOR risk score predicts healthcare in adults with severe or difficult-to-treat asthma.
Miller MK; Lee JH; Blanc PD; Pasta DJ; Gujrathi S; Barron H; Wenzel SE; Weiss ST;
Eur Respir J; 2006 Dec; 28(6):1145-55. PubMed ID: 16870656
[TBL] [Abstract][Full Text] [Related]
43. Overview of changes to asthma guidelines: diagnosis and screening.
Pollart SM; Elward KS
Am Fam Physician; 2009 May; 79(9):761-7. PubMed ID: 20141095
[TBL] [Abstract][Full Text] [Related]
44. Subacute lack of asthma control and acute asthma exacerbation history as predictors of subsequent acute asthma exacerbations: evidence from managed care data.
O'Connor RD; Bleecker ER; Long A; Tashkin D; Peters S; Klingman D; Gutierrez B
J Asthma; 2010 May; 47(4):422-8. PubMed ID: 20528597
[TBL] [Abstract][Full Text] [Related]
45. Level of asthma control and health care utilization in Asia-Pacific countries.
Gold LS; Thompson P; Salvi S; Faruqi RA; Sullivan SD
Respir Med; 2014 Feb; 108(2):271-7. PubMed ID: 24406243
[TBL] [Abstract][Full Text] [Related]
46. Treatment with inhaled mometasone furoate reduces short-acting β(2) agonist claims and increases adherence compared to fluticasone propionate in asthma patients.
Navaratnam P; Friedman HS; Urdaneta E
Value Health; 2011; 14(2):339-46. PubMed ID: 21402302
[TBL] [Abstract][Full Text] [Related]
47. Budesonide/formoterol maintenance and reliever therapy versus conventional best practice.
Demoly P; Louis R; Søes-Petersen U; Naya I; Carlsheimer A; Worth H; Almeida J; Sears MR
Respir Med; 2009 Nov; 103(11):1623-32. PubMed ID: 19762222
[TBL] [Abstract][Full Text] [Related]
48. Effect of asthma exacerbations on health care costs among asthmatic patients with moderate and severe persistent asthma.
Ivanova JI; Bergman R; Birnbaum HG; Colice GL; Silverman RA; McLaurin K
J Allergy Clin Immunol; 2012 May; 129(5):1229-35. PubMed ID: 22326484
[TBL] [Abstract][Full Text] [Related]
49. Evaluation of the asthma control test: a reliable determinant of disease stability and a predictor of future exacerbations.
Ko FW; Hui DS; Leung TF; Chu HY; Wong GW; Tung AH; Ngai JC; Ng SS; Lai CK
Respirology; 2012 Feb; 17(2):370-8. PubMed ID: 22107482
[TBL] [Abstract][Full Text] [Related]
50. Forced expiratory volume in 1 second percentage improves the classification of severity among children with asthma.
Fuhlbrigge AL; Weiss ST; Kuntz KM; Paltiel AD;
Pediatrics; 2006 Aug; 118(2):e347-55. PubMed ID: 16864642
[TBL] [Abstract][Full Text] [Related]
51. Predictors of uncontrolled asthma in adult and pediatric patients: analysis of the Asthma Control Characteristics and Prevalence Survey Studies (ACCESS).
Stanford RH; Gilsenan AW; Ziemiecki R; Zhou X; Lincourt WR; Ortega H
J Asthma; 2010 Apr; 47(3):257-62. PubMed ID: 20210612
[TBL] [Abstract][Full Text] [Related]
52. Drug utilization and asthma control among young Danish adults with asthma. Analyses of trends and determinants.
Davidsen JR
Dan Med J; 2012 Aug; 59(8):B4501. PubMed ID: 22849986
[TBL] [Abstract][Full Text] [Related]
53. Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study.
Magnan A; Meunier JP; Saugnac C; Gasteau J; Neukirch F
Allergy; 2008 Mar; 63(3):292-8. PubMed ID: 18028246
[TBL] [Abstract][Full Text] [Related]
54. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
55. A randomized controlled evaluation of specialist nurse education following accident and emergency department attendance for acute asthma.
Levy ML; Robb M; Allen J; Doherty C; Bland JM; Winter RJ
Respir Med; 2000 Sep; 94(9):900-8. PubMed ID: 11001084
[TBL] [Abstract][Full Text] [Related]
56. Asthma management and asthma control in São Paulo, Brazil and Uppsala, Sweden: a questionnaire-based comparison.
Skorup P; Rizzo LV; Machado-Boman L; Janson C
Clin Respir J; 2009 Jan; 3(1):22-8. PubMed ID: 20298368
[TBL] [Abstract][Full Text] [Related]
57. Evaluation of risk factors and health outcomes among persons with asthma.
Smith K; Warholak T; Armstrong E; Leib M; Rehfeld R; Malone D
J Asthma; 2009 Apr; 46(3):234-7. PubMed ID: 19373629
[TBL] [Abstract][Full Text] [Related]
58. A comparison of budesonide/formoterol maintenance and reliever therapy versus conventional best practice in asthma management in Spain.
Quirce S; Barcina C; Plaza V; Calvo E; Muñoz M; Ampudia R; Capel M
J Asthma; 2011 Oct; 48(8):839-47. PubMed ID: 21942354
[TBL] [Abstract][Full Text] [Related]
59. Relationship of asthma control to asthma exacerbations using surrogate markers within a managed care database.
Schatz M; Zeiger RS; Yang SJ; Chen W; Crawford WW; Sajjan SG; Allen-Ramey F
Am J Manag Care; 2010 May; 16(5):327-33. PubMed ID: 20469953
[TBL] [Abstract][Full Text] [Related]
60. Validation of a beta-agonist long-term asthma control scale derived from computerized pharmacy data.
Schatz M; Zeiger RS; Vollmer WM; Mosen D; Apter AJ; Stibolt TB; Leong A; Johnson MS; Mendoza G; Cook EF
J Allergy Clin Immunol; 2006 May; 117(5):995-1000. PubMed ID: 16675324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
